We are live on ! Find out more
NHG

NQ HCIF GP Portfolio holdings

AUM $50.2M
1-Year Est. Return 45.53%
This Fund
S&P 500
This Quarter Est. Return
-12.36%
1 Year Est. Return
-45.53%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$52.5M
AUM Growth
–
Cap. Flow
+$54.1M
Cap. Flow %
103.1%
Top 10 Hldgs %
100%
Holding
1
New
1
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
RVNC
Revance Therapeutics, Inc.
RVNC
+$54.1M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RVNC
1
DELISTED
Revance Therapeutics, Inc.
RVNC
$52.5M 100%
+3,096,650
New +$54.1M

Similar funds

RVGI
RRE Ventures GP III New York $50.9M AUM 40.71% 1-Year Est. Return
ACI
Advance Capital I Southfield, Michigan $49.4M AUM 18.84% 1-Year Est. Return
RAM
Ramsey Asset Management Reston, Virginia $48.8M AUM 3.93% 1-Year Est. Return
BS
Bow Street New York $52.4M AUM 2.22% 1-Year Est. Return
LSVM
Lone Star Value Management Old Greenwich, Connecticut $52.7M AUM 30.18% 1-Year Est. Return
HPA
Hilltop Park Associates New York $54.1M AUM 92.24% 1-Year Est. Return
CCM
Convector Capital Management New York $54.5M AUM 11.63% 1-Year Est. Return
CC
Consector Capital New York $45.9M AUM 4.93% 1-Year Est. Return

NQ HCIF GP's Q4 2014 Portfolio in Review

Q4 2014 is the first quarter with a 13F filing on record for NQ HCIF GP, which disclosed 1 position worth $52.5M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Revance Therapeutics, Inc.: 3,096,650 shares worth $52.5M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • NQ HCIF GP's largest Q4 2014 buy was Revance Therapeutics, Inc.: 3,096,650 shares worth $52.5M.
  • NQ HCIF GP's ten largest holdings make up 100% of its $52.5M portfolio in Q4 2014.
  • NQ HCIF GP disclosed 1 position in Q4 2014, its first 13F filing on record.

Based on NQ HCIF GP's 13F filing for Q4 2014, filed 17 Feb 2015.